Peter Maag, PhD
Chief Executive Officer
Kyverna Therapuetics
Emeryville, CA, USA
Disclosure information not submitted.
Georg Schett, MD (he/him/his)
Friedrich-Alexander-Universität Erlangen-Nürnberg
Erlangen, Germany
Disclosure information not submitted.
Jörg Distler, MD
Director of the Rheumatology Clinic and the Hiller Research Center
University Hospital Duesseldorf and HHU
Duesseldorf, Germany
Disclosure information not submitted.
Lorinda Chung, MD, MS
Professor of Medicine and Dermatology
Stanford University
Woodside, CA, United States
Disclosure information not submitted.
Roberto Caricchio, MD
Professor of Medicine, Chief of the Division of Rheumatology
University of Massachusetts Chan Medical School
Worcester, Massachusetts, United States
Disclosure information not submitted.
World leaders in the field will present and discuss advances in the treatment of B-cell mediated autoimmune diseases using anti-CD19 CAR T-cell therapy, share experience to date, and address questions from the audience. Developed and offered by Kyverna. Not an official program of the ACR.
Non-CME